LINCOLN POLICY GROUP for FRESENIUS MEDICAL CARE NORTH AMERICA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COOKAB HASHEMI | — |
| RUDY MISSMAR | — |
| COLIN ROSKEY | — |
| THOMAS A SCULLY | — |
Medicare/Medicaid MMM
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Foreign entity interest: Fresenius Medical Care AG, identified on form LD-1, has an interest in the activities of its U.S. subsidiary Fresenius Medical Care North America on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| COOKAB HASHEMI | — |
| RUDY MISSMAR | — |
| COLIN ROSKEY | — |
| THOMAS A SCULLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.